Dementia Care: Home- and Community-Based Services (R21 and R01 Clinical Trial Not Allowed)
Grants for research on the outcomes of care for persons with Alzheimer's disease and related dementia by identifying home- and community-based services used, as well as barriers to accessing care and unmet needs. Explaining geographic disparities, such as urban versus rural, in access to and quality of care is a suggested research topic. Geographic coverage: Nationwide -- National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 17, 2019 Category: American Health Source Type: funding
Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-037 from the NIH Guide for Grants and Contracts. The Funding Opportunity Announcement (FOA) invites applications seeking to examine the outcomes of care for persons with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) through identifying home and community-based services (HCBS) used, as well as barriers to accessing these types of care, and unmet needs of persons with AD/ADRD concerning care and services. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 16, 2019 Category: Research Source Type: funding
Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-038 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to examine the outcomes of care for persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by identifying home- and community-based services (HCBS) used, as well as barriers to accessing these types of care and unmet needs of persons with AD/ADRD concerning care and services in these settings. This R21 FOA is particularly seeking applications that will develop new measurement instruments in this field and ways to improve data quality and access. (So...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 16, 2019 Category: Research Source Type: funding
Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-20-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support hypothesis-testing research on the systems, cellular and/or molecular mechanisms and consequences of TDP-43 proteinopathy in common dementias using whole animal models, animal/human cellular model systems, as well as postmortem tissue and other biospecimens. Research on TDP-43 proteinopathy in common dementias, including the clinical syndrome of Alzheimer's disease (AD), multiple etiology dementias (MED) and related dementia syndromes is the focus of this FOA. In additio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2019 Category: Research Source Type: funding
Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-031 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support short courses geared to behavioral and social scientists who have existing expertise in aging research and can make research contributions in Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) with additional knowledge about the diseaseand related research resources. Fields of behavioral and social science research relevant for this FOA are health economics, labor economics, health services research, healthcare policy, public policy, demography, sociology, social epidemiology, psychology,...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 14, 2019 Category: Research Source Type: funding
Notice of Change to Key Dates for PAS-19-210 "Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)"
Notice NOT-NS-19-081 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 6, 2019 Category: Research Source Type: funding
Notice of Change to RFA-AG-20-022 "Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional)"
Notice NOT-AG-19-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 29, 2019 Category: Research Source Type: funding
Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications proposing to conduct research involving pragmatic clinical trials on dissemination and implementation of practical approaches to hypertension treatment and control strategies among older adults with multimorbidity in order to prevent sequelae, including mild cognitive impairment and dementia. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding
Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-039 from the NIH Guide for Grants and Contracts. (Reissue of RFA-NS-16-021, PAR-18-413) Diffuse brain white matter disease is highly prevalent in the elderly, and has been clinically associated with vascular contributions to cognitive impairment and dementia (VCID) in both men and women. Diffuse white matter disease is thought to include a variety of pathologies including demyelination and/or fiber loss due to multifocal infarction and local ischemia. It is often accompanied by arteriosclerosis in deep penetrating arteries, multiple infarcts in the basal ganglia, brainstem or cerebellum. Th...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2019 Category: Research Source Type: funding
Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to conduct new research on automobile technology for signaling early signs of cognitive impairment in older drivers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 11, 2019 Category: Research Source Type: funding
Lucidity in Dementia (R21/R33 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-017 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21/R33 phased innovation mechanism to support initial exploratory/developmental aims during the R21 phase followed by further expanded aims during the R33 phase. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 6, 2019 Category: Research Source Type: funding
Lucidity in Dementia (R21 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-016 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21 mechanism to support initial exploratory/developmental aims that will serve as the foundation for future studies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 6, 2019 Category: Research Source Type: funding
Invitation for Input on the 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and their Caregivers
Notice NOT-AG-19-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2019 Category: Research Source Type: funding
Notice of Change to Key Date for PAR-19-170 "Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)".
Notice NOT-NS-19-046 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
Funding Opportunity PAS-19-210 from the NIH Guide for Grants and Contracts. This purpose of this FOA is to identify risk factors for dementia progression in PDD. Applicants must have access to well-characterized populations of PDD patients that have been followed longitudinally that they can continue to follow with clinical assessments and biospecimen collection until autopsy. Research should propose to identify clinical, pathological and/or biospecimen factors that predict which patients will develop cognitive impairment and/or dementia. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 7, 2019 Category: Research Source Type: funding
